IGC PHARMA, INC. Payments for Purchase of Other Assets
IGC PHARMA, INC. (IGC) reported Payments for Purchase of Other Assets of $286.17 thousand for the 9-month period ending 2017-12-31, per its 10-Q filed 2018-02-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForPurchaseOfOtherAssets1 · last filed 2018-02-20
- IGC PHARMA, INC. payments for purchase of other assets for the quarter ending 2017-12-31 was $149.89K.
- IGC PHARMA, INC. payments for purchase of other assets for the quarter ending 2017-03-31 was $0.00.
- IGC PHARMA, INC. payments for purchase of other assets for the quarter ending 2016-12-31 was $0.00.
- IGC PHARMA, INC. payments for purchase of other assets for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- IGC PHARMA, INC. payments for purchase of other assets for fiscal 2016 was $1.35K, a 99.78% decline from fiscal 2015.
- IGC PHARMA, INC. payments for purchase of other assets for fiscal 2015 was $607.47K.
| Period end | Payments for Purchase of Other Assets 3 month | Payments for Purchase of Other Assets 6 month | Payments for Purchase of Other Assets 9 month | Payments for Purchase of Other Assets 12 month |
|---|---|---|---|---|
| 2017-12-31 | $149.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-20 | $286.17K 10-Q · filed 2018-02-20 | ||
| 2017-09-30 | $136.28K 10-Q · filed 2017-11-17 | |||
| 2017-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-14 | $0.00 derived: sum of 2 quarters · filed 2018-02-20 | $0.00 10-K · filed 2017-07-14 | |
| 2016-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-20 | $0.00 10-Q · filed 2018-02-20 | ||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-17 | |||
| 2016-03-31 | $1.35K 10-K · filed 2017-07-14 | |||
| 2015-03-31 | $607.47K 10-K · filed 2016-07-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |